Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IDEAYA Biosciences (IDYA) Invested Capital (2019 - 2025)

IDEAYA Biosciences' Invested Capital history spans 7 years, with the latest figure at $1.0 billion for Q4 2025.

  • For Q4 2025, Invested Capital fell 3.42% year-over-year to $1.0 billion; the TTM value through Dec 2025 reached $1.0 billion, down 3.42%, while the annual FY2025 figure was $1.0 billion, 3.42% down from the prior year.
  • Invested Capital for Q4 2025 was $1.0 billion at IDEAYA Biosciences, down from $1.1 billion in the prior quarter.
  • Across five years, Invested Capital topped out at $1.2 billion in Q3 2024 and bottomed at $233.1 million in Q1 2021.
  • The 5-year median for Invested Capital is $504.8 million (2023), against an average of $626.9 million.
  • The largest annual shift saw Invested Capital soared 180.19% in 2024 before it fell 7.49% in 2025.
  • A 5-year view of Invested Capital shows it stood at $301.5 million in 2021, then increased by 15.9% to $349.5 million in 2022, then soared by 77.73% to $621.1 million in 2023, then soared by 70.53% to $1.1 billion in 2024, then decreased by 3.42% to $1.0 billion in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Invested Capital are $1.0 billion (Q4 2025), $1.1 billion (Q3 2025), and $959.7 million (Q2 2025).